Bio-Techne
TECH
529 hedge funds and large institutions have $10.4B invested in Bio-Techne in 2023 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 176 increasing their positions, 214 reducing their positions, and 56 closing their positions.
90% more call options, than puts
Call options by funds: $19.6M | Put options by funds: $10.3M
7% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 56
0% more funds holding
Funds holding: 528 → 529 (+1)
0.18% more ownership
Funds ownership: 96.01% → 96.19% (+0.18%)
16% less capital invested
Capital invested by funds: $12.3B → $10.4B (-$1.97B)
18% less repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 214
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| 1 |
BlackRock
New York
|
+$108M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$95.9M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$44.4M |
| 4 |
Select Equity Group
New York
|
+$28.6M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$27.7M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$80.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$64.4M |
| 3 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$39.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$34.4M |
TECH Hedge Fund Activity: Q3 2023 in Review
529 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2023, worth a combined $10.4B — down 16% from $12.3B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new TECH positions and 56 closed out — a net gain of 4 holders — while 176 added to existing stakes and 214 trimmed.
The largest buyer was BlackRock, adding an estimated $108M. The largest seller was Ameriprise, cutting an estimated $80.2M.
- 529 institutional investors held Bio-Techne (TECH) as of Q3 2023, up from 528 in Q2 2023.
- Funds reported $10.4B of Bio-Techne stock for Q3 2023, down 16% quarter-over-quarter.
- 60 funds opened new Bio-Techne positions in Q3 2023 and 56 closed out, a net change of +4 holders.
- The largest Bio-Techne buyer in Q3 2023 was BlackRock, an estimated $108M added.
- The largest Bio-Techne seller in Q3 2023 was Ameriprise, an estimated $80.2M sold.
Based on aggregated 13F filings for Q3 2023.